Encompass Health (NYSE:EHC) shares have climbed 15.7% to $124.41 over the past six months. This gain outpaced the S&P 500, which rose 13.5% during the same period. The rehabilitation provider operates 161 specialized facilities across 37 states and Puerto Rico, treating patients recovering from conditions such as strokes and hip fractures.
Financial performance shows an expansion in free cash flow margin, which rose by 3.4 percentage points over the last five years. For the trailing 12 months, Encompass Health’s free cash flow margin stood at 12.6%. This metric reflects actual cash available rather than accounting profits.
Investors look to return on invested capital (ROIC) to gauge how efficiently a company uses its funding to generate operating profit. Encompass Health’s five-year average ROIC was 15.8%, a figure that exceeded other healthcare companies by a wide margin according to StockStory analysis. The firm suggests this indicates management’s ability to invest in growth opportunities that produce results for shareholders.
Growth metrics reveal a mixed picture for the outpatient and specialty care segment. Same-store sales, which track revenue changes at locations open for at least a year, averaged 4% year-on-year growth over the last two years. StockStory notes this performance slightly lagged the sector, potentially suggesting the company may need to adjust its strategy or pricing, which could disrupt operations.
At the current share price of $124.41, Encompass Health trades at a forward price-to-earnings ratio of 19.4 times. StockStory states that positive characteristics outweigh the negatives but directs readers to a full research report for a detailed buy, sell, or hold recommendation.